BlueWind Medical

BlueWind Medical is a medical device company founded in 2010 by the Rainbow Medical Group in Israel. The company specializes in neuromodulation therapy for urge urinary incontinence (UUI) and overactive bladder conditions. BlueWind develops implantable tibial neuromodulation devices that provide drug-free, minimally invasive treatment options aimed at enhancing patients' quality of life. The flagship product, the Revi System, is an implantable device placed near the ankle through a simple outpatient procedure. It sends electrical signals from the tibial nerve to the brain to help manage symptoms of UUI. Clinical studies show that nearly 80% of patients experienced significant reductions in leaks after two years, with a high level of patient satisfaction. The therapy is personalized, allowing patients to control their treatment sessions. BlueWind Medical is committed to innovation, holding a robust intellectual property portfolio and receiving FDA De Novo marketing authorization for the Revi System in August 2023. The company partners with healthcare providers to deliver advanced treatment options for patients suffering from urinary incontinence and overactive bladder.

• Employees 98
• Founded 2010
• Annual Revenue $5800000
• Total Funding $64000000